Purpose: To assess the impact of primary surgery, partial and total penectomy, and of inguinal lymphadenectomy on health-related quality of life (HRQoL) and the sexual function of penile cancer patients. Materials and Methods: We invited 15 patients surgically treated for penile cancer in the Regional Hospital of Specialized Medicine of the Yucatan Peninsula between 2012 and 2016 to complete the SF-36 quality of life and International Index of Erectile Function (IIEF-5) sexual function questionnaires. We evaluated the impact of primary surgery type and inguinal lymphadenectomy on the outcome of HRQoL and sexual function. Results: A total of 10 patients (66%) completed the SF-36 questionnaire. Surgery type and extent of resection were overall not associated significantly with worse outcomes on the assessed domains of quality of life. However, men treated with partial penectomy reported significantly more pain (p = 0.0547) than men treated with total penectomy. Similarly, men who underwent lymphadenectomy reported significantly more pain (p = 0.0547) than those who were spared from the procedure due to the -primary tumor´s stage and grade. Sexual function was severely affected (IIEF mean = 6.5) in patients treated with partial penectomy. Conclusions: Although partial penectomy and lymphadenectomy were significantly associated with more postoperative pain, no differences were observed in other HRQoL domains. Sexual function was severely affected in patients treated with partial penectomy.

Keywords:
Penile carcinoma, Penectomy, Inguinal lymphadenectomy, Sexual function and health-related quality of life
1.
Correa AF, Handorf E, Joshi SS, Geynisman DM, Kutikov A, Chen DY, et al: Differences in survival by receipt of lymph node dissection in patients with invasive penile cancer: results from NCDB. J Urol 2017: 1–7.
2.
Skeppner E, Windahl T, Andersson SO, Fugl-meyer KS: Treatment-seeking, aspects of sexual activity and life satisfaction in men with laser-treated penile carcinoma. Eur Urol 2008; 54: 631–639.
3.
Maddineni SB, Lau MM, Sangar VK: Identifying the needs of penile cancer sufferers: A systematic review of the quality of life, psychosexual and psychosocial literature in penile cancer. BMC Urol 2009; 9: 1–6.
4.
Romero FR, Romero KR, Mattos MA, Garcia CR, Fernandes Rde C, Perez MD: Sexual function after partial penectomy for penile cancer. Urology 2005; 66: 1292–1295.
5.
Audenet F, Sfakianos JP: Psychosocial impact of penile carcinoma. Transl Androl Urol 2017; 6: 874–878.
6.
D’Ancona CA, Botega NJ, De Moraes C, Lavoura NS Jr, Santos JK, Rodrigues Netto N Jr: Quality of life after partial penectomy for penile carcinoma. Urology 1997; 50: 593–596.
7.
Hakenberg OW, Compérat E, Minhas S, Necchi A, Protzel C, Watkin N: EAU Guidelines on Penile Cancer 2018.
8.
Opjordsmoen S, Fossa SD: Quality of life in patients treated for penile cancer. A follow-up study. Br J Urol 1994; 74: 652–657.
9.
Witty K, Branney P, Evans J, Bullen K, White A, Eardley I: The impact of surgical treatment for penile cancer – patients’ perspectives. Eur J Oncol Nurs 2013; 17: 661–667.
10.
Hakenberg OW, Compérat EM, Minhas S, Necchi A, Protzel C, Watkin N: EAU guidelines on penile cancer: 2014 update. Eur Urol 2015; 67: 142–150.
11.
Branney P, Witty K, Eardley I: Patients’ experiences of penile cancer. Eur Urol 2011; 59: 959–961.
12.
Hoffman MA, Renshaw AA, Loughlin KR: Squamous cell carcinoma of the penis and microscopic pathologic margins: how much margin is needed for local cure? Cancer 1997; 85: 1565–1568.
13.
Agrawal A, Pai D, Ananthakrishnan N, Smile SR, Ratnakar C: The histological extent of the local spread of carcinoma of the penis and its therapeutic implications. BJU Int 2000; 85: 299–301.
14.
Lont AP, Gallee MP, Meinhardt W, van Tinteren H, Horenblas S: Penis conserving treatment for T1 and T2 penile carcinoma: clinical implications of a local recurrence. J Urol 2006; 176: 575–580.
15.
Gambachidze D, Lebacle C, Maroun P, Escande A, Bossi A, Blanchard P, et al: Long-term evaluation of urinary, sexual, and quality of life outcomes after brachytherapy for penile carcinoma. Brachytherapy 2018; 17: 221–226.
16.
Hadway P, Corbishley CM, Watkin NA: Total glans resurfacing for premalignant lesions of the penis: initial outcome data. BJU Int 2006; 98: 532–536.
17.
Sansalone S, Silvani M, Leonardi R, Vespasiani G, Iacovelli V: Sexual outcomes after partial penectomy for penile cancer: results from a multi-institutional study. Asian J Androl 2017; 19: 57–61.
18.
Mortensen GL, Jakobsen JK: Patient perspectives on quality of life after penile cancer. Dan Med J 2013; 60:A4655.
19.
Kieffer JM, Djajadiningrat RS, van Muilekom EA, Graafland NM, Horenblas S, Aaronson NK: Quality of life for patients treated for penile cancer. J Urol 2014; 192: 1105–1110.
20.
Sosnowski R, Kulpa M, Kosowicz M, Wolski JK, Kuczkiewicz O, Moskal K, et al: Quality of life in penile carcinoma patients – post-total penectomy. Cent Eur J Urol 2016; 69: 204–211.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.